Enoxaparin Sodium Injection
Product Images NDC 55154-3542

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 55154-3542). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Enoxaparin Figure A (Image 01)

An instructional illustration showing two hands demonstrating how to remove the cap from a syringe. The arrows indicate the direction for pulling the cap off the syringe needle, suggesting the proper way to prepare the injection device for use.*

FDA Label Image

Enoxaparin Figure B (Image 02)

An instructional illustration showing a person administering a subcutaneous injection of Enoxaparin Sodium. The image depicts a hand holding a prefilled syringe and injecting into the fatty tissue layer under the skin, indicated by an arrow pointing to the injection site.*

FDA Label Image

Enoxaparin Figure C (Image 03)

An instructional illustration showing a hand holding a syringe with a needle inserted at an angle into the skin of an arm, demonstrating a subcutaneous injection technique for Enoxaparin Sodium injection.*

FDA Label Image

Enoxaparin Figure D (Image 04)

An instructional illustration showing a hand holding a syringe, likely depicting the proper technique for administering an injection. The syringe barrel and plunger are visible, with an arrow indicating the direction of plunger movement.*

FDA Label Image

Enoxaparin Figure E (Image 05)

An instructional illustration showing a gloved hand disposing of a used syringe into a biohazard sharps container marked with a biohazard symbol. The image emphasizes safe disposal procedure for injection equipment.*

FDA Label Image

Enoxaparin Sodium Chemical Structure (Image 06)

Chemical structure diagram of the active ingredient Enoxaparin Sodium. The image shows polysaccharide chains with labeled substituents R1 and R2, along with details about the percentage of the polysaccharide chain containing 1,6 anhydro derivative on the reducing end.*

FDA Label Image

Figure-1 (Image 07)

A forest plot chart presenting relative risk comparisons between unfractionated heparin (UHF) and Enoxaparin sodium injection across various patient subgroups, including sex, age, infarct location, diabetes status, prior myocardial infarction, fibrinolytic agent type, time to treatment, and PCI status at 30 days. The chart shows relative risk values with confidence intervals, indicating the comparative effectiveness of Enoxaparin versus UHF for each subgroup and overall in a patient population of 20,479.*

FDA Label Image

Figure-2 (Image 08)

A survival analysis chart showing the hazard distribution function over 30 days for Enoxaparin Sodium injection compared to UFH (unfractionated heparin). The x-axis represents time to death or myocardial re-infarction in days, while the y-axis shows the hazard distribution function. The chart includes a log-rank test result with p<0.0001 and a small inset graph showing results at 1 year with p=0.0111. Below is a table listing the number of patients at risk for both Enoxaparin and UFH groups at various time points.*

FDA Label Image

Bag Label (Image 09)

Label for Enoxaparin Sodium Injection USP 30 mg/0.3 mL in 5 x 0.3 mL single dose syringes with automatic safety device. The label shows this is for subcutaneous injection, includes storage instructions, manufacturer Shenzhen Techdow Pharmaceutical Co., Ltd, and distributor Cardinal Health, Dublin, OH. It also contains warnings about child safety and instructions for syringe safety device use.*

FDA Label Image

Bag Label (Image 10)

Packaging label for Enoxaparin Sodium Injection USP 40 mg/0.4 mL, supplied as 5 single-dose syringes with automatic safety device for subcutaneous injection. The label includes usage directions, manufacturer Shenzhen Techdow Pharmaceutical Co., Ltd., and distributor Cardinal Health, Dublin, OH.*

FDA Label Image

Bag Label (Image 11)

Label for Enoxaparin Sodium Injection, USP 60 mg/0.6 mL provided in a package of 5 single-dose syringes with automatic safety device for subcutaneous injection. The label includes storage instructions, manufacturer Shenzhen Techdow Pharmaceutical Co., Ltd for Sandoz Inc., and distributor Cardinal Health, Dublin, OH. Directions for use and safety warnings are also detailed on the label.*

FDA Label Image

Bag Label (Image 12)

Text panels for Enoxaparin Sodium Injection 80 mg/0.8 mL single-dose syringes with automatic safety device. Includes dosing and administration details, storage instructions, warnings, manufacturing and distribution information, and detailed directions for use and activation of the syringe's safety system.*

FDA Label Image

Bag Label (Image 13)

This panel provides detailed usage instructions for Enoxaparin Sodium Injection 100 mg/mL, a single-dose subcutaneous injection with automatic safety device. It includes dosage form details, manufacturer and distributor information, storage conditions, warnings, and step-by-step directions on using and activating the syringe's safety system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.